![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solut... Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.05 | 2.57731958763 | 1.94 | 2 | 1.775 | 252958 | 1.90463163 | CS |
4 | -0.07 | -3.39805825243 | 2.06 | 2.11 | 1.775 | 222304 | 1.95924559 | CS |
12 | -0.25 | -11.1607142857 | 2.24 | 2.37 | 1.7 | 299073 | 2.03020109 | CS |
26 | 0.46 | 30.0653594771 | 1.53 | 3.12 | 1.35 | 374864 | 2.16014827 | CS |
52 | 1.003 | 101.621073961 | 0.987 | 3.12 | 0.661 | 328149 | 1.74820548 | CS |
156 | -2.18 | -52.278177458 | 4.17 | 4.96 | 0.45 | 311045 | 1.98256433 | CS |
260 | -0.64 | -24.3346007605 | 2.63 | 4.96 | 0.45 | 318986 | 2.06126211 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions